Chronic kidney disease: open trials in Estonia

3 open trials have a site in Estonia. Registry data; only the trial team decides who can take part.

NCT07241390
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Liina Viitas OÜ, Paernu · Estendo Private Clinic, Tallinn · North Estonia Medical Centre Foundation, Tallinn · Center for Clinical and Basic Research AS, Tallinn
Registry updated 2026-11-04
NCT06243731
A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
Research · Takeda
North Estonia Medical Centre Foundation, Tallinn · Tartu University Hospital, Tartu
Registry updated 2025-12-16
NCT06873880
Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients
Research · University of Tartu
Institute of Clinical Medicine, Tartu
Registry updated 2025-03-13

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)